EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Why intrinsic reduced susceptibility in rare fungal pathogens should be differentiated from intrinsic resistance: an ISHAM conceptual framework and narrative review

Cornelia Lass-Flörl iD, Stephan Steixner iD, Angelika Bauer, Jacques F Meis iD, Arnaldo L Colombo iD, Oliver A Cornely, Arunaloke Chakrabarti iD, Ferry Hagen iD, Amanda Ribeiro Dos Santos iD, Amir Seyedmousavi iD, Shivaprakash M Rudramurthy, Roya Vahedi-Shahandashti iD und 1 weitere

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.00263-26 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Cornelia Lass-Flörl und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hygiene and Medical Microbiology, ECMM Excellence Diamond Centre of Medical Mycology, Medical University of Innsbruck, Innsbruck, Austri…. Hauptthemen laut MEDLINE: Antifungal Agents, Drug Resistance, Fungal, Fungi. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Universität Innsbruck, Working Group on Aspergillus terreus (A Novel Amphotericin B Resistance Detection Method for Combating Aspergillus Section Terrei Infections), Medical University of Innsbruck.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate interpretation of antifungal minimum inhibitory concentrations (MICs) requires distinguishing species-level intrinsic phenotypes from isolate-level acquired resistance. Many fungi exhibit intrinsic reduced susceptibility (IRS) reflected by wild-type (WT) MIC distributions that are shifted toward higher values (uniformly or with a high-MIC tail). This may lead to the misclassification of high-end WT isolates as resistant and compromise surveillance and cross-center comparability, particularly for rare fungi lacking established breakpoints. In this review, we propose a pragmatic and standardized framework to distinguish intrinsic phenotypes (normal susceptibility, IRS, intrinsic resistance) from acquired resistance based on species-specific WT MIC distributions and standardized WT/non-wild-type (NWT) reporting. This framework is specifically intended to guide interpretation in data-limited settings where WT distributions and epidemiological cut-off values (ECOFFs) are not yet established. MICs within the unimodal species-specific WT range, even if high, should be interpreted as potentially reflecting IRS and not as acquired resistance. Only MICs clearly right-shifted beyond the WT range should be classified as NWT by epidemiological cut-off values or, if unavailable, as putative NWT, and considered candidates for acquired resistance. When breakpoints are lacking, WT versus NWT reporting with explicit comments on IRS/intrinsic resistance is preferable to forced susceptible/resistant (S/R) categorization. In the absence of established WT distributions or ECOFFs, such classification remains provisional and should rely on descriptive MIC patterns, available data sets, and clinical context. Integrating these biological interpretations with pharmacokinetics/pharmacodynamics and clinical context supports optimized dosing, avoids inappropriate drug exclusion, and enables consistent surveillance and multicenter comparisons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsDrug Resistance, FungalFungiMicrobial Sensitivity TestsHumansMycoses

Stichwörter der Autor:innen

acquired resistanceantifungal resistanceintrinsic reduced susceptibilityintrinsic resistancerare fungi

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Institute of Hygiene and Medical Microbiology, ECMM Excellence Diamond Centre of Medical Mycology, Medical University of Innsbruck, Innsbruck, Austria.
  • Radboudumc-CWZ Center of Expertise for Mycology, Nijmegen, the Netherlands.
  • Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Excellence Center for Medical Mycology, University of Cologne, Cologne, Germany.
  • Antimicrobial Resistance Institute of São Paulo (ARIES), Federal University of São Paulo, São Paulo, Brazil.
  • Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University of Cologne, Cologne, Germany.
  • Department I of Internal Medicine, Division of Infectious Diseases, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine, University Hospital Cologne, Cologne, Germany.

ORCID-Profile: Cornelia Lass-Flörl, Stephan Steixner, Jacques F Meis, Arnaldo L Colombo, Arunaloke Chakrabarti, Ferry Hagen, Amanda Ribeiro Dos Santos, Amir Seyedmousavi, Roya Vahedi-Shahandashti

Förderung

  • Medizinische Universität Innsbruck
  • Working Group on Aspergillus terreus (A Novel Amphotericin B Resistance Detection Method for Combating Aspergillus Section Terrei Infections)
  • Medical University of Innsbruck

Zitieren

APA

Lass-Flörl, C., Steixner, S., Bauer, A., Meis, J. F., Colombo, A. L., Cornely, O. A., Chakrabarti, A., Hagen, F., Ribeiro Dos Santos, A., Seyedmousavi, A., Rudramurthy, S. M., Vahedi-Shahandashti, R., & ISHAM Working Group on Intrinsic Antifungal Resistance (2026). Why intrinsic reduced susceptibility in rare fungal pathogens should be differentiated from intrinsic resistance: an ISHAM conceptual framework and narrative review. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00263-26

Vancouver

Lass-Flörl C, Steixner S, Bauer A, Meis JF, Colombo AL, Cornely OA, et al. Why intrinsic reduced susceptibility in rare fungal pathogens should be differentiated from intrinsic resistance: an ISHAM conceptual framework and narrative review. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00263-26

BibTeX
@article{LassFlrl2026,
  author = {Lass-Flörl, Cornelia and Steixner, Stephan and Bauer, Angelika and Meis, Jacques F and Colombo, Arnaldo L and Cornely, Oliver A and Chakrabarti, Arunaloke and Hagen, Ferry and Ribeiro Dos Santos, Amanda and Seyedmousavi, Amir and Rudramurthy, Shivaprakash M and Vahedi-Shahandashti, Roya and ISHAM Working Group on Intrinsic Antifungal Resistance, ISHAM Working Group on Intrinsic Antifungal Resistance},
  title = {Why intrinsic reduced susceptibility in rare fungal pathogens should be differentiated from intrinsic resistance: an ISHAM conceptual framework and narrative review},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.00263-26}
}
Kostenlos starten →